Bixiye
QP38-21 Commercial and MHCP Pharmacy Benefit Exclusion for Abecma®
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Natiijooyinka Raadinta
Soo bandhiga 1641 - 1650 ee natiijooyinka 4296
Bixiye
QP33-21 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) Criteria: Winlevi®
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP25-21 Reminders Related to the Submission of Prior Authorizations and Subsequent Claims
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
QP32-21 Reminder: New Claim Edits For Professional Lab Claims Missing Required Data
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
QP27-21 MHCP Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
QP24-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective June 1, 2021
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
QP26-21 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
QP30-21 Reference Guides for Commercial Networks and Medicare Products
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
QP29-21 Commercial and MHCP Pharmacy Benefit Update – Growth Hormone Notification
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021